Specifics of Russian Pharmaceutical Market in the XXI Century: Original Drugs or Generics? | CMAC

Specifics of Russian Pharmaceutical Market in the XXI Century: Original Drugs or Generics?

Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(4):335-340

Section
Type
Journal article

Abstract

This paper reviews some issues concerning comparison of pharmaceutical quality and bioequivalence between original drug products and their generics. A need for periodic routine monitoring of the currently marketed drug products and more stringent governmental control for quality of being approved drugs are also considered. Under current market glut in the pharmaceutical sector, the means of control through the additional drug quality assessment performed by independent institutes with appropriate facilities is proposed.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared